SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-015968
Filing Date
2024-06-07
Accepted
2024-06-07 16:21:31
Documents
2
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 form4-06072024_080627.html 4  
1 form4-06072024_080627.xml 4 4047
2 ex24-06072024_080633.htm EX-24 6947
  Complete submission text file 0001415889-24-015968.txt   12522
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address
Menzel Garry E (Reporting) CIK: 0001556064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 241029774

Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)